Back to Capital World Investors Capital World Investors

TEVATEVA
19 quarters

Position history for Capital World InvestorsCapital World Investors's holdings in TEVA PHARMACEUTICAL-SP ADR

Yes. Capital World Investors holds 12,536,035 shares of TEVA (Teva Pharmaceutical), worth $424.7M, as of its Q2 2026 13F filing. It increased the position by 3,702,469 shares (+41.9%) from Q1 2026. Capital World Investors has held TEVA since Q4 2025, across 3 quarterly 13F filings. TEVA is 0.1% of Capital World Investors' reported 13F portfolio.

Current Value

$424.7M

Current Shares

12.5M

Total Value Change

+$59.2M

Total Shares Change

-27.1M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
12.5M
+41.9%
$424.7M0.1%$33.88
42
2026-Q1
Increased
8.8M
+274.1%
$266.1M0.0%$30.12
50
2025-Q4
New
2.4M
-
$73.7M0.0%$31.21
41
2023-Q3
Exited
0
-100.0%
$00.0%$10.20
0
2023-Q2
Decreased
119,417
-99.8%
$903,9630.0%$7.53
0
2023-Q1
Increased
50.6M
+0.1%
$448.2M0.1%$8.85
31
2022-Q4
Increased
50.6M
+28.6%
$461.1M0.1%$9.12
39
2022-Q3
New
39.3M
-
$317.4M0.1%$8.07
43
2021-Q4
Exited
0
-100.0%
$00.0%$8.01
0
2021-Q3
Decreased
6.2M
-87.5%
$60.2M0.0%$9.74
0
2021-Q2
Decreased
49.3M
-7.0%
$488.4M0.1%$9.90
0
2021-Q1
Increased
53M
+0.3%
$611.8M0.1%$11.54
38
2020-Q4
Increased
52.9M
+0.1%
$510.3M0.1%$9.65
31
2020-Q3
Increased
52.8M
+21.6%
$475.8M0.1%$9.01
45
2020-Q2
Increased
43.4M
+31.3%
$535.5M0.1%$12.33
48
2020-Q1
Decreased
33.1M
-7.3%
$297.1M0.1%$8.98
0
2019-Q4
Increased
35.7M
+6.1%
$350M0.1%$9.80
33
2019-Q3
Decreased
33.6M
-15.0%
$231.5M0.1%$6.88
0
2019-Q2
First report
39.6M
-
$365.6M0.1%$9.23
0

Other major holders of TEVA: BlackRock, Inc., Capital Research Global Investors

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used